Cognitive Improvements With Active Singing in Dementia

This article originally appeared here.
Share this content:
Cognitive Improvements With Active Singing in Dementia
Cognitive Improvements With Active Singing in Dementia

THURSDAY, May 14, 2015 (HealthDay News) -- An active singing program can improve cognition and life satisfaction among individuals with dementia in an assisted living facility, according to a letter to the editor published in the April issue of the Journal of the American Geriatrics Society.

Linda E. Maguire, from the Johns Hopkins University in Baltimore, and colleagues examined the impact of active singing on measures of cognition and life satisfaction at an assisted living facility. Forty-five participants received three vocal music sessions per week (independent residents: 18 singers, nine listeners; dementia: nine singers, nine listeners).

The researchers found that independent residents had significantly higher scores than those with dementia on the mini-mental state examination (MMSE; P < 0.001). Among participants with dementia, there was a significant interaction between pre-and post-study MMSE scores of singers and listeners (P = 0.04). Initial scores were not significantly different, but at the end of the study, singers had significantly higher MMSE scores than listeners (P = 0.008). Similarly, initially, there was no significant difference in clock-drawing ability between listeners and singers, but after treatment, singers scored significantly higher (P = 0.009). Compared with listeners, singers (independent living and dementia groups) had significantly higher Satisfaction with Life Scale scores (P < 0.001).

"These data show that an active singing program, using an innovative approach, led to significant improvement in cognitive ability in individuals with dementia," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths